Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis

BACKGROUND: Patients with chronic renal insufficiency on maintenance haemodialysis face an increased risk of COVID-19 induced mortality and impaired vaccine responses. To date, only a few studies have addressed SARS-CoV-2 vaccine elicited immunity in this immunocompromised population. METHODS: We as...

Descripción completa

Detalles Bibliográficos
Autores principales: Strengert, Monika, Becker, Matthias, Ramos, Gema Morillas, Dulovic, Alex, Gruber, Jens, Juengling, Jennifer, Lürken, Karsten, Beigel, Andrea, Wrenger, Eike, Lonnemann, Gerhard, Cossmann, Anne, Stankov, Metodi V., Dopfer-Jablonka, Alexandra, Kaiser, Philipp D., Traenkle, Bjoern, Rothbauer, Ulrich, Krause, Gérard, Schneiderhan-Marra, Nicole, Behrens, Georg M.N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357427/
https://www.ncbi.nlm.nih.gov/pubmed/34391096
http://dx.doi.org/10.1016/j.ebiom.2021.103524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357427/
https://www.ncbi.nlm.nih.gov/pubmed/34391096
http://dx.doi.org/10.1016/j.ebiom.2021.103524

Ejemplares similares